PuSH - Publication Server of Helmholtz Zentrum München

24 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Blank, S. et al.: Prevalence of Hymenoptera venom allergy and sensitization in the population-representative German KORA cohort. Allergo J. Int., accepted (2019)
Mehlich, J.* et al.: The basophil activation test differentiates between patients with alpha-gal syndrome and asymptomatic alpha-gal sensitization. J. Allergy Clin. Immunol. 143, 182-189 (2019)
Russkamp, D. et al.: IL-4 receptor α blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma. Allergy, accepted (2019)
André, V. et al.: Laboratory mouse housing conditions can be improved using common environmental enrichment without compromising data. PLoS Biol. 16:e2005019 (2018)
Blank, S. ; Bilò, M.B.* & Ollert, M.*: Component-resolved diagnostics to direct in venom immunotherapy: Important steps towards precision medicine. Clin. Exp. Allergy 48, 354-364 (2018)
Dittmar, M. et al.: Immunological characterization of Polistes dominula venom and identification of the hyaluronidase Pol d 2. Allergy 73, 42-42 (2018)
Eberlein, B.* et al.: Differences of Pol d 3 and Ves v 3 induced basophil activation between Spanish and German insect venom allergic patients. Allergy 73, 634-635 (2018)
Kistler, T. et al.: Autoreactive IgE occurs naturally during childhood and is negatively correlated with allergic sensitization at age 10. Allergy 73, 829-829 (2018)
Nikolakopoulou, P.* et al.: Streptozotocin-induced beta-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain. Sci. Rep. 8:11335 (2018)
Russkamp, D. et al.: Characterization of the honeybee venom proteins C1q-like protein and PVF1 and their allergenic potential. Toxicon 150, 198-206 (2018)
Russkamp, D.* et al.: A thermosensitive hydrogel as delivery system for immunomodulatory substances and allergens during allergen-specific immunotherapy. Allergy 73, 233-233 (2018)
Russkamp, D.* et al.: Sustained inhibition of the IL4/IL13 receptor complex during allergen specific immunotherapy. Allergy 73, 232-232 (2018)
Schiener, M. et al.: The high molecular weight dipeptidyl peptidase IV Pol d 3 is a major allergen of Polistes dominula venom. Sci. Rep. 8:1318 (2018)
Schmidt, M.O.* et al.: The role of Fibroblast growth factor binding protein 1 in skin carcinogenesis and inflammation. J. Invest. Dermatol. 138, 179-188 (2018)
Treise, I. et al.: Defective immuno- and thymoproteasome assembly causes severe immunodeficiency. Sci. Rep. 8:5975 (2018)
Aguilar-Pimentel, J.A. et al.: Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma. PLoS ONE 12:e0178563 (2017)
Blank, S. et al.: Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy. Hum. Vaccin. Immunother. 13, 2482-2489 (2017)
Fuchs, H. et al.: Understanding gene functions and disease mechanisms: Phenotyping pipelines in the German Mouse Clinic. Behav. Brain Res. 352, 187-196 (2017)
Graessel, A. et al.: Interference into JAK/stat signalling-a concept for improved allergen-specific immunotherapy? Allergy 72, 40-40 (2017)
Russkamp, D. et al.: Component-resolved allergen content of therapeutic honeybee venom extracts. Allergy 72, 18-18 (2017)